Neurocrine Bioscience buy Guggenheim
Start price
02.05.24
/
50%
€131.25
Target price
02.05.25
€158.42
Performance (%)
-14.10%
Price
15:09
€112.75
Summary
This prediction is currently active. The prediction for Neurocrine Bioscience disappoints with a performance of -14.10%. This prediction currently runs until 02.05.25. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | -17.708% | -17.708% |
| iShares Core DAX® | 1.743% | 1.903% |
| iShares Nasdaq 100 | -2.088% | -0.640% |
| iShares Nikkei 225® | 1.306% | 4.161% |
| iShares S&P 500 | -0.093% | 0.169% |
Comments by Guggenheim for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at Guggenheim from $164.00 to $170.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Guggenheim for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€140.30
02.08.24
02.08.24
€164.90
02.08.25
02.08.25
-19.89%
15:09
15:09
